SCHEMBL21701579

SCHEMBL21701579

O=C(Nc1ccc(N2CCCN(c3ncccn3)CC2)cc1C(=O)O)c1ccco1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.53
▸ ALDH1A1 P00352 5/20 0.49
▸ HSD17B10 Q99714 2/20 0.49
▸ MAPK1 P28482 2/20 0.48
▸ MAPT P10636 5/20 0.47
▸ GAA P10253 2/20 0.47
▸ ALOX15 P16050 2/20 0.47
▸ CYP1A2 P05177 1/20 0.46
▸ HPGD P15428 3/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ TSHR P16473 2/20 0.46
▸ NPC1 O15118 4/20 0.44
▸ RAB9A P51151 4/20 0.44
▸ SERPINE1 P05121 2/20 0.44
▸ LMNA P02545 2/20 0.44
▸ TP53 P04637 1/20 0.44
▸ NFKB1 P19838 1/20 0.44
▸ CASP1 P29466 1/20 0.44
▸ NFKB2 Q00653 1/20 0.44
▸ RELA Q04206 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21701591 0.97 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1HSD17B10MAPK1MAPT
SCHEMBL21701587 0.90 ALDH1A1 (0.53) SMN1; SMN2ALDH1A1HSD17B10MAPK1MAPT
SCHEMBL21683001 0.86 ALDH1A1 (0.56) SMN1; SMN2ALDH1A1HSD17B10MAPK1MAPT
SCHEMBL21701474 0.81 SMN1; SMN2 (0.58) SMN1; SMN2ALDH1A1HSD17B10MAPK1MAPT
SCHEMBL21701494 0.79 F10 (0.59) ALDH1A1MAPTRAB9ASERPINE1
SCHEMBL21701605 0.75 MAPT (0.57) MAPTNPC1RAB9ASERPINE1
SCHEMBL21701478 0.70 CYP1A2 (0.61) SMN1; SMN2ALDH1A1HSD17B10MAPK1MAPT
SCHEMBL6815137 0.70 GFER (0.71) SMN1; SMN2ALDH1A1MAPK1MAPTGAA
SCHEMBL14075179 0.70 LTC4S (0.66) SMN1; SMN2MAPK1GAACYP1A2KDM4E
SCHEMBL6933566 0.70 CYP1A2 (0.61) SMN1; SMN2ALDH1A1HSD17B10MAPK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020033944-A2 NON-POLYAMINE BASED POLYAMINE TRANSPORT INHIBITORS AND THEIR USE IN THE TREATMENT OF HUMAN CANCERS UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) 2020-02-13 — — WO disclosed
Send feedback